Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Breast Cancer

  Free Subscription

Articles published in Genes Chromosomes Cancer

Retrieve available abstracts of 7 articles:
HTML format
Text format

Single Articles

    September 2017
  1. WANG X, Teer JK, Tousignant RN, Levin AM, et al
    Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
    Genes Chromosomes Cancer. 2017 Sep 10. doi: 10.1002/gcc.22503.
    PubMed     Text format     Abstract available

    July 2017
  2. BUBIEN V, Bonnet F, Dupiot-Chiron J, Barouk-Simonet E, et al
    Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: a proof of principle study.
    Genes Chromosomes Cancer. 2017 Jul 10. doi: 10.1002/gcc.22482.
    PubMed     Text format     Abstract available

    June 2017
  3. KULKARNI S, Bill A, Godse NR, Khan NI, et al
    TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
    Genes Chromosomes Cancer. 2017;56:460-471.
    PubMed     Text format     Abstract available

    April 2017
  4. SUN H, Liu T, Zhu D, Dong X, et al
    HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.
    Genes Chromosomes Cancer. 2017 Apr 10. doi: 10.1002/gcc.22463.
    PubMed     Text format     Abstract available

    March 2017
  5. FEJZO MS, Anderson L, Chen HW, Guandique E, et al
    Proteasome Ubiquitin Receptor PSMD4 is an Amplification Target in Breast Cancer and May Predict Sensitivity to PARPi.
    Genes Chromosomes Cancer. 2017 Mar 18. doi: 10.1002/gcc.22459.
    PubMed     Text format     Abstract available

    October 2016
  6. PFARR N, Penzel R, Endris V, Lier C, et al
    Targeted Next Generation Sequencing Enables Reliable Detection of HER2 (ERBB2) Status in Breast Cancer and Provides Ancillary Information of Clinical Relevance.
    Genes Chromosomes Cancer. 2016 Oct 28. doi: 10.1002/gcc.22431.
    PubMed     Text format     Abstract available

    September 2016
  7. DAMIANO V, Brisotto G, Borgna S, di Gennaro A, et al
    Epigenetic Silencing of miR-200c in Breast Cancer Is Associated with Aggressiveness and Is Modulated by ZEB1.
    Genes Chromosomes Cancer. 2016 Sep 22. doi: 10.1002/gcc.22422.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.